GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bliss GVS Pharma Ltd (NSE:BLISSGVS) » Definitions » Gross Margin %

Bliss GVS Pharma (NSE:BLISSGVS) Gross Margin % : 51.82% (As of Mar. 2024)


View and export this data going back to 2010. Start your Free Trial

What is Bliss GVS Pharma Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. Bliss GVS Pharma's Gross Profit for the three months ended in Mar. 2024 was ₹1,027 Mil. Bliss GVS Pharma's Revenue for the three months ended in Mar. 2024 was ₹1,981 Mil. Therefore, Bliss GVS Pharma's Gross Margin % for the quarter that ended in Mar. 2024 was 51.82%.


The historical rank and industry rank for Bliss GVS Pharma's Gross Margin % or its related term are showing as below:

NSE:BLISSGVS' s Gross Margin % Range Over the Past 10 Years
Min: 30.93   Med: 46.82   Max: 56.39
Current: 50.39


During the past 13 years, the highest Gross Margin % of Bliss GVS Pharma was 56.39%. The lowest was 30.93%. And the median was 46.82%.

NSE:BLISSGVS's Gross Margin % is ranked better than
56.45% of 985 companies
in the Drug Manufacturers industry
Industry Median: 47 vs NSE:BLISSGVS: 50.39

Bliss GVS Pharma had a gross margin of 51.82% for the quarter that ended in Mar. 2024 => Durable competitive advantage

The 5-Year average Growth Rate of Gross Margin for Bliss GVS Pharma was 10.10% per year.


Bliss GVS Pharma Gross Margin % Historical Data

The historical data trend for Bliss GVS Pharma's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bliss GVS Pharma Gross Margin % Chart

Bliss GVS Pharma Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Gross Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 35.48 42.02 47.02 46.60 50.39

Bliss GVS Pharma Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Gross Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 41.02 47.08 52.93 48.94 51.82

Competitive Comparison of Bliss GVS Pharma's Gross Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Bliss GVS Pharma's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bliss GVS Pharma's Gross Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Bliss GVS Pharma's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Bliss GVS Pharma's Gross Margin % falls into.



Bliss GVS Pharma Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

Bliss GVS Pharma's Gross Margin for the fiscal year that ended in Mar. 2024 is calculated as

Gross Margin % (A: Mar. 2024 )=Gross Profit (A: Mar. 2024 ) / Revenue (A: Mar. 2024 )
=3881.3 / 7702.449
=(Revenue - Cost of Goods Sold) / Revenue
=(7702.449 - 3821.157) / 7702.449
=50.39 %

Bliss GVS Pharma's Gross Margin for the quarter that ended in Mar. 2024 is calculated as


Gross Margin % (Q: Mar. 2024 )=Gross Profit (Q: Mar. 2024 ) / Revenue (Q: Mar. 2024 )
=1026.6 / 1981.283
=(Revenue - Cost of Goods Sold) / Revenue
=(1981.283 - 954.678) / 1981.283
=51.82 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Bliss GVS Pharma  (NSE:BLISSGVS) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Bliss GVS Pharma had a gross margin of 51.82% for the quarter that ended in Mar. 2024 => Durable competitive advantage


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


Bliss GVS Pharma Gross Margin % Related Terms

Thank you for viewing the detailed overview of Bliss GVS Pharma's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Bliss GVS Pharma (NSE:BLISSGVS) Business Description

Traded in Other Exchanges
Address
Saki Vihar Road, 102, Hyde Park, Andheri (East), Mumbai, MH, IND, 400 072
Bliss GVS Pharma Ltd is an India-based company engaged in the manufacturing, marketing, trading, and export of pharmaceutical products. Geographically, it derives a majority of revenue from Outside India. Some of its brands include Lonart, P-Alaxin, Funbact, and Lofnac, and others. It offers pharma products including tablets, suspensions, suppositories, and injections. The majority of its revenue is derived from Exports.

Bliss GVS Pharma (NSE:BLISSGVS) Headlines

No Headlines